Loss of Heterozygosity at the Brca1 Locus as a Marker of Sen- Sitivity for Adjuvant Chemotherapy in Hereditary Ovarian Cancer
Biological Markers in Fundamental and Clinical Medicine (collection of abstracts)
doi 10.29256/01.03.2017.escbm10
Full Text
Open PDFAbstract
Available in full text
Date
December 27, 2017
Authors
Publisher
European Scientific Center Biological Marker s.r.o.